Relmada Therapeutics recently announced positive data for its investigational drug NDV-01 in high-risk non-muscle invasive bladder cancer.
Show original
Clinical results show that this therapy achieved a 76% complete remission rate during the 12-month treatment cycle, a figure that significantly surpasses the expected outcomes of existing standard therapies, bringing new hope to patients.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$68,954.1
+2.53%
Ethereum
ETH
$2,025.06
+3.31%
Tether USDt
USDT
$1
+0.04%
BNB
BNB
$637.71
+3.13%
XRP
XRP
$1.37
+1.13%
USDC
USDC
$1
+0.03%
Solana
SOL
$85.56
+3.77%
TRON
TRX
$0.2861
-1.44%
Dogecoin
DOGE
$0.09100
+1.38%
Cardano
ADA
$0.2577
+1.73%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now